ArticleMolecular and clinical oncology2018

Long-acting muscarinic antagonist and long-acting β2-agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery.

Takashi Makino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.